NFYC antibody
Principal name
NFYC antibody
Alternative names for NFYC antibody
Nuclear transcription factor Y subunit gamma, Transactivator HSM-1/2
SwissProt ID
Q13952 (Human)
Gene ID
4802 (NFYC)
Ncbi ID
9606, CAI16533, NP_055038, NP_001136059.1, NP_055038.2, AAH05003.1, NM_001142587, NM_001142588, NM_001142589, NM_001142590, NP_001136061, NM_014223
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection))
Background of NFYC antibody
NFYC is one subunit of a trimeric complex, forming a highly conserved transcription factor that binds with high specificity to CCAAT motifs in the promoter regions in a variety of genes. NFYC forms a tight dimer with the B subunit, a prerequisite for subunit A association. The resulting trimer binds to DNA with high specificity and affinity.The protein encoded by this gene is one subunit of a trimeric complex, forming a highly conserved transcription factor that binds with high specificity to CCAAT motifs in the promoter regions in a variety of genes. This gene product, subunit C, forms a tight dimer with the B subunit, a prerequisite for subunit A association. The resulting trimer binds to DNA with high specificity and affinity. Subunits B and C each contain a histone-like motif. Observation of the histone nature of these subunits is supported by two types of evidence; protein sequence alignments and experiments with mutants. Additional regulation, preliminarily supported by the EST database, may be represented by alternative splicing in this subunit.
General readings
Ichikawa, S. et al., J. Bone Miner. Res. 25(8): 1821-1829 (2010)
Murai-Takeda, A. et al., J. Biol. Chem. 285(11): 8084-8093 (2010)
Ceribelli, M. et al., J. Biol. Chem. 284(49): 34189-34200 (2009)
Yamanaka, K. et al., Genomics 94(4): 219-227 (2009)
Horikawa, Y. et al., Clin. Cancer Res. 14(23): 7956-7962 (2008)
















Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA314260 | NFYC antibody |
||||||
| Rabbit polyclonal anti-NFYC antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP20495PU-N | NFYC antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€370.00
|
||
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP52868PU-N | NFYC (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300060 | NFYC (transcript variant 2) |
||||
| Recombinant protein of human nuclear transcription factor Y, gamma (NFYC), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP326680 | NFYC (transcript variant 4) |
||||
| Purified recombinant protein of Homo sapiens nuclear transcription factor Y, gamma (NFYC), transcript variant 4 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY428190 | NFYC overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY428191 | NFYC overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY428192 | NFYC overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY428193 | NFYC overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |








+1 additional image


